D. E. Shaw & Co., Inc. - ANTARES PHARMA INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$976,000
+257.5%
238,233
+248.3%
0.00%
Q4 2020$273,000
+702.9%
68,395
+442.2%
0.00%
Q3 2020$34,000
-78.5%
12,615
-78.1%
0.00%
Q2 2020$158,000
+62.9%
57,680
+40.3%
0.00%
Q1 2020$97,000
-42.6%
41,114
+14.3%
0.00%
Q4 2019$169,000
+116.7%
35,967
+19.1%
0.00%
Q2 2018$78,000
-86.1%
30,211
-84.7%
0.00%
-100.0%
Q1 2017$561,000
-28.2%
197,653
-41.0%
0.00%0.0%
Q4 2016$781,000
+136.7%
335,217
+70.6%
0.00%0.0%
Q3 2016$330,000
+187.0%
196,449
+78.8%
0.00%
Q2 2016$115,000
-12.9%
109,844
-27.6%
0.00%
Q1 2016$132,000
-38.3%
151,649
-14.4%
0.00%
Q4 2015$214,000
+78.3%
177,146
+151.5%
0.00%
Q3 2015$120,000
-62.4%
70,423
-54.1%
0.00%
Q2 2015$319,000
-12.6%
153,337
+14.0%
0.00%
-100.0%
Q1 2015$365,000
+34.2%
134,509
+26.9%
0.00%
Q4 2014$272,000
+466.7%
105,998
+797.6%
0.00%
Q3 2013$48,00011,8090.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders